The First Crispr Medicine Just Got Approved

The gene-editing therapy, called Casgevy, uses Crispr to prevent debilitating pain in patients with sickle cell disease. It also eliminates the need for regular blood transfusions in people with beta thalassemia.

from Feed: All Latest https://ift.tt/VsjvRy1
via IFTTT

No comments:

Post a Comment

Your 'Max Heart Rate' Is Probably Wrong

If you’ve ever worried about your heart rate during exercise being too high or too low, you’ll want to read this. Your "heart rate zone...